Sernova Corp. (TSE:SVA - Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as C$0.37 and last traded at C$0.37, with a volume of 144113 shares changing hands. The stock had previously closed at C$0.40.
Analyst Ratings Changes
Separately, Raymond James set a C$1.50 target price on shares of Sernova and gave the company a "market perform" rating in a research report on Thursday, April 4th.
Get Our Latest Analysis on Sernova
Sernova Price Performance
The stock's 50-day simple moving average is C$0.52 and its 200 day simple moving average is C$0.62. The company has a quick ratio of 18.11, a current ratio of 1.20 and a debt-to-equity ratio of 16.55. The company has a market cap of C$115.30 million, a price-to-earnings ratio of -2.92 and a beta of 1.60.
Sernova (TSE:SVA - Get Free Report) last announced its earnings results on Monday, March 18th. The company reported C($0.03) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of C($0.03). On average, equities research analysts anticipate that Sernova Corp. will post -0.08 EPS for the current fiscal year.
About Sernova
(
Get Free Report)
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sernova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.
While Sernova currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
